biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > I do find the "thumbs up" tallies funny

<< Previous

Bullboard Posts

Next >>

Post by zwerp2000on Jan 25, 2023 5:09pm

223 Views

Post# 35246416

I do find the "thumbs up" tallies funny

One poster, multiple aliases hitting the thumbs up button. I don't think there are more than 4 people posting on this board yet when JD posts, within 5 minutes there are 5-6+ thumbs up to his post. LOL. JD, do you really think you are fooling us? This is why i can't leave this board. It is just a clown world

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks